loader

World Tenders & Procurement Opportunities

Czech Republic - Drug delivery - DRUG SUBSTANCE - DABRAFENIB - L01EC02 - Antineoplastic agents

World Biggest Tenders Source

This tender with title Czech Republic - Drug delivery - DRUG SUBSTANCE - DABRAFENIB - L01EC02 - Antineoplastic agents --
Dodávka léků - LÉČIVÁ LÁTKA - DABRAFENIB - L01EC02
has been published on Bidding Source portal dated 03 Apr 2023 for the country of Czech Republic. It has been categorized on Antineoplastic agents. For similar tenders you can see tenders mentioned below of this page.


Dodávka léků - LÉČIVÁ LÁTKA - DABRAFENIB - L01EC02

General Information

Czech Republic - Drug delivery - DRUG SUBSTANCE - DABRAFENIB - L01EC02 - Antineoplastic agents

Dodávka léků - LÉČIVÁ LÁTKA - DABRAFENIB - L01EC02
Invitation for Bids
2023/S 063-188223
Czech Republic
Czech Republic-Prague
3 Apr 2023
24 Apr 2023
English
Antineoplastic agents

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

312262- Czech Republic – Antineoplastic agents – Medicinal products containing nilotinib 2025 Czech Republic 290236- Czech Republic – Antineoplastic agents – Drug supplies – Active substance nintedanib – ATC L01EX09 Czech Republic 290840- Czech Republic – Antineoplastic agents – Drug supplies – Active substance pertuzumab, trastuzumab – ATC L01FY01 Czech Republic 251750-Awarded - Czech Republic – Antineoplastic agents – Antineoplastika -- <b>Contract Value: 546 362,20 CZK</b> Czech Republic 256567-Awarded - Czech Republic – Antineoplastic agents – Vybrané léčivé přípravky pro onkologii -- <b>Contract Value: 632 945,84 CZK</b> Czech Republic 256835-Awarded - Czech Republic – Antineoplastic agents – Dodávky léčivého přípravku s obsahem léčivé látky NIVOLUMAB a IPILIMUMAB -- <b>Contract Value: 2 045 306,78 CZK</b> Czech Republic 258134-Awarded - Czech Republic – Antineoplastic agents – Léčivý přípravek s obsahem pembrolizumabu -- <b>Contract Value: 3 918 901,28 CZK</b> Czech Republic 222742-Awarded - Czech Republic – Antineoplastic agents – Biologická léčba 2024 I -- <b>Contract Value: 47 017 365,20 CZK </b> Czech Republic 180775- Czech Republic – Antineoplastic agents – Dodávky léků – Léčivá látka pembrolizumab – ATC L01FF02 – opakovaná VZ Czech Republic 177851- Czech Republic – Antineoplastic agents – Dodávky léčivých přípravků s účinnou látkou AFLIBERCEPT 2025 Czech Republic
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans